Cargando…
Double megatherapy and autologous bone marrow transplantation for advanced neuroblastoma: the LMCE2 study.
In the LMCE1 study using a single course of megatherapy most of the relapses occurred during the first 2 years after autologous bone marrow transplantation. A second pilot study (LMCE2) was therefore set up using a double harvest/double graft approach with two different megatherapy regimens. Objecti...
Autores principales: | Philip, T., Ladenstein, R., Zucker, J. M., Pinkerton, R., Bouffet, E., Louis, D., Siegert, W., Bernard, J. L., Frappaz, D., Coze, C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968211/ https://www.ncbi.nlm.nih.gov/pubmed/8427772 |
Ejemplares similares
-
The LMCE5 unselected cohort of 25 children consecutively diagnosed with untreated stage 4 neuroblastoma over 1 year at diagnosis
por: Frappaz, D, et al.
Publicado: (2002) -
Immunological detection of neuroblastoma cells in bone marrow harvested for autologous transplantation.
por: Combaret, V., et al.
Publicado: (1989) -
Histological, cytological and immunological analyses are complementary for the detection of neuroblastoma cells in bone marrow.
por: Favrot, M. C., et al.
Publicado: (1986) -
Melphalan, Etoposide, and Carboplatin Megatherapy with Autologous Stem Cell Transplantation in Children with Relapsing or Therapy-Resistant Extracranial Germ-Cell Tumors—A Retrospective Analysis
por: Ussowicz, Marek, et al.
Publicado: (2020) -
High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma.
por: Pritchard, J., et al.
Publicado: (1982)